Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Barker goes in to bat for bioscience

Barker goes in to bat for bioscience

Auckland August 5 2014: Biotechnologist and patent attorney Dr Will Barker has tackled some tough assignments in his career. Now he has a new one.

Barker has taken on the job of leading NZBIO, New Zealand's principal independent organisation representing the full breadth of interests across the biotechnology sector. Once it thrived with Government backing, but in the restructured, contestable world of science funding, NZBIO has to make sure biotech gets not only heard, but its fair share of the pie.

Barker says he can point to multiple examples why Kiwis should continue to back bioscience. He comes from one of the most significant ones in recent times – LanzaTech. As a qualified patent attorney, Dr Barker's led LanzaTech’s IP strategy development and commercialisation activities.

Now a multinational, multimillion dollar company and a world leader in gas fermentation technology, LanzaTech in the main has headed offshore and is headquartered in the United States. Barker, for his belief in New Zealand’s potential in bioscience, for family reasons and for their lifestyle, has elected to remain.

Since gaining his PhD in synthetic chemistry in the United Kingdom, Barker has held a number of roles in New Zealand, including post-doctoral research and laboratory investigation. He says the science community in New Zealand is innovative and entrepreneurial and he wants to do his bit to encourage and to help continue develop that.

Barker replaces Dr George Slim whom the chairman of NZBIO Dr Gavin Ross says worked hard and contributed strongly to the organisation’s 11 year history.

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Auckland Outage: Power Mostly Restored Overnight

Vector wishes to advise that all but 324 customers have been restored overnight. These customers are spread throughout the network in small pockets. The main St Johns feeder was restored around midnight allowing most of the customers in all affected areas to have power this morning. More>>

ALSO:

Half Empty: Dairy Prices Drop To Lowest Since August 2009

Dairy product prices fell to the lowest level in more than five years in the latest GlobalDairyTrade auction, led by declines in butter milk powder and whole milk powder. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news